How it works

Our technology seamlessly integrates five distinct layer of deep clinical intelligence
to guide treatment selections.

Keti AI

Tracks how individual breast, cervical and ovarian cancer patient respond to specific treatment regimens dynamically over time.

Feeds real world clinical results back into our core neural networks to continuously sharpen the predictive accuracy of future recommendations.

Identifies early, sub clinical indicators of therapy failure long before standard imaging scans or symptom progression can pick them up.

Compares current active patient profiles against an optimized repository of past clinical journeys to predict treatment survival probabilities.

Analyzes tumor evolution patterns to explain specific genetic, sub clonal or alternative pathway survival mechanisms driving drug resistance.

See Keti AI in action

Request a personalized demo

Discover how our AI platform helps clinicians make smarter, faster and more confident treatment
decisions that improve patient outcomes.

92.8% Sensitivity

21.0% Malignant Cases

60.5% Normal

18.5% Benign Cases

Deep learning model processing your data

Preprocessing MRI Data Complete

Detecting Tumor Regions 31%

Analyzing Cell Morphology Pending

Processing Genomic Markers Pending

Computing Risk Prediction Pending

2/5 Stages Complete

26% Overall Progress

~24s Time Remaining